SC 13G: Aura Biosciences, Inc.
Ticker: AURA · Form: SC 13G · Filed: 2024-10-22T00:00:00.000Z
Sentiment: neutral
Topics: sc-13g
AI Summary
SC 13G filing by Aura Biosciences, Inc..
Risk Assessment
Risk Level: low
From the Filing
EDGAR Filing Documents for 0002012383-24-001608 This page uses Javascript. Your browser either doesn't support Javascript or you have it turned off. To see this page as it is meant to appear please use a Javascript enabled browser. SEC.gov EDGAR Latest Filings Filings search tools Filing Detail SEC Home Company Search Current Page Form SC 13G - Statement of Beneficial Ownership by Certain Investors: SEC Accession No. 0002012383-24-001608 Filing Date 2024-10-22 Accepted 2024-10-22 18:06:48 Documents 1 Document Format Files Seq Description Document Type Size 1 us05153u1079_102224.txt SC 13G 11874 Complete submission text file 0002012383-24-001608.txt 13577 Mailing Address 80 GUEST STREET BOSTON MA 01235 Business Address 80 GUEST STREET BOSTON MA 01235 (617)500-8864 Aura Biosciences, Inc. (Subject) CIK : 0001501796 (see all company filings) EIN. : 320271970 | State of Incorp.: DE | Fiscal Year End: 1231 Type: SC 13G | Act: 34 | File No.: 005-92997 | Film No.: 241387334 SIC : 2836 Biological Products, (No Diagnostic Substances) (CF Office: 03 Life Sciences) Mailing Address 50 HUDSON YARDS NEW YORK NY 10001 Business Address 50 HUDSON YARDS NEW YORK NY 10001 (212) 810-5300 BlackRock, Inc. (Filed by) CIK : 0002012383 (see all company filings) EIN. : 991116001 | State of Incorp.: DE | Fiscal Year End: 1231 Type: SC 13G SIC : 6211 Security Brokers, Dealers & Flotation Companies (CF Office: 02 Finance)